These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 12370860

  • 41. Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa.
    De Marinis L, Mancini A, Valle D, Bianchi A, Gentilella R, Milardi D, Mascadri C, Giustina A.
    Metabolism; 2000 Feb; 49(2):155-9. PubMed ID: 10690937
    [Abstract] [Full Text] [Related]

  • 42. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.
    degli Uberti EC, Ambrosio MR, Cella SG, Margutti AR, Trasforini G, Rigamonti AE, Petrone E, Müller EE.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2885-8. PubMed ID: 9284714
    [Abstract] [Full Text] [Related]

  • 43. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L, Bianchi A, Mancini A, Gentilella R, Perrelli M, Giampietro A, Porcelli T, Tilaro L, Fusco A, Valle D, Tacchino RM.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [Abstract] [Full Text] [Related]

  • 44. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA, Turgeon DK, Friberg RD, Watkins PB, Barkan AL.
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [Abstract] [Full Text] [Related]

  • 45. Serum insulin but not leptin is associated with spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in normal volunteers with and without weight loss.
    Manglik S, Cobanov B, Flores G, Nadjafi R, Tayek JA.
    Metabolism; 1998 Sep; 47(9):1127-33. PubMed ID: 9751243
    [Abstract] [Full Text] [Related]

  • 46. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset.
    Maghnie M, Cavigioli F, Tinelli C, Autelli M, Aricò M, Aimaretti G, Ghigo E.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2740-4. PubMed ID: 12050243
    [Abstract] [Full Text] [Related]

  • 47. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC, Vestergaard P, Jakobsen PE, Falhof J, Laurberg P.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
    [Abstract] [Full Text] [Related]

  • 48. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults.
    Popovic V, Leal A, Micic D, Koppeschaar HP, Torres E, Paramo C, Obradovic S, Dieguez C, Casanueva FF.
    Lancet; 2000 Sep 30; 356(9236):1137-42. PubMed ID: 11030292
    [Abstract] [Full Text] [Related]

  • 49. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J, Iglesias P, Sastre J, Méndez J, Selgas R, Gómez-Pan A.
    Nephron; 1996 Sep 30; 74(3):548-54. PubMed ID: 8938679
    [Abstract] [Full Text] [Related]

  • 50. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME.
    J Clin Endocrinol Metab; 1998 Jun 30; 83(6):2018-28. PubMed ID: 9626134
    [Abstract] [Full Text] [Related]

  • 51. Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients.
    Díez JJ, Iglesias P, Aguilera A, Bajo MA, Selgas R.
    Nephrol Dial Transplant; 1999 Jul 30; 14(7):1704-9. PubMed ID: 10435880
    [Abstract] [Full Text] [Related]

  • 52. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
    Catalina PF, Mallo F, Andrade MA, García-Mayor RV, Diéguez C.
    J Clin Endocrinol Metab; 1998 Oct 30; 83(10):3663-7. PubMed ID: 9768681
    [Abstract] [Full Text] [Related]

  • 53. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F, Palomba S, Colao A, Russo T, Dentico C, Tauchmanovà L, Savastano S, Nappi C, Sultan C, Zullo F, Lombardi G.
    J Endocrinol Invest; 2003 Feb 30; 26(2):117-22. PubMed ID: 12739737
    [Abstract] [Full Text] [Related]

  • 54. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval.
    Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM.
    J Clin Endocrinol Metab; 2003 Jan 30; 88(1):95-102. PubMed ID: 12519836
    [Abstract] [Full Text] [Related]

  • 55. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
    Maccario M, Aimaretti G, Grottoli S, Gauna C, Tassone F, Corneli G, Rossetto R, Wu Z, Strasburger CJ, Ghigo E.
    Int J Obes Relat Metab Disord; 2001 Aug 30; 25(8):1233-9. PubMed ID: 11477509
    [Abstract] [Full Text] [Related]

  • 56. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
    Gianotti L, Rolla M, Arvat E, Belliti D, Valetto MR, Ferdeghini M, Ghigo E, Müller EE.
    Biol Psychiatry; 1999 Feb 01; 45(3):334-9. PubMed ID: 10023511
    [Abstract] [Full Text] [Related]

  • 57. The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6.
    Popovic V, Pekic S, Golubicic I, Doknic M, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 2002 May 01; 87(5):2095-9. PubMed ID: 11994347
    [Abstract] [Full Text] [Related]

  • 58. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M, Frohman LA.
    J Clin Endocrinol Metab; 1990 Jul 01; 71(1):157-63. PubMed ID: 1973420
    [Abstract] [Full Text] [Related]

  • 59. Acute hyperglycemia and activation of the beta-adrenergic system exhibit synergistic inhibitory actions on growth hormone (GH) releasing hormone-induced GH release.
    Park C, Yang I, Woo J, Kim S, Kim J, Kim Y, Park S.
    Eur J Endocrinol; 2003 Jun 01; 148(6):635-40. PubMed ID: 12773135
    [Abstract] [Full Text] [Related]

  • 60. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G, Marzullo P, Ragusa L, Sartorio A, Trifirò G, Liuzzi A, Crinò A, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology.
    Clin Endocrinol (Oxf); 2006 Oct 01; 65(4):492-9. PubMed ID: 16984242
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.